BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$4.13
+0.38 (+10.13%)
Open$3.77
Previous Close$3.75
Day High$4.14
Day Low$3.71
52W High$135.00
52W Low$4.95
Volume—
Avg Volume15.8K
Market Cap39.01M
P/E Ratio—
EPS$-53.28
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+499.3% upside
Current
$4.13
$4.13
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.36M | 5.82M | 6.86M |
| Net Income | -563,828 | -513,311 | -545,732 |
| Profit Margin | -8.9% | -8.8% | -8.0% |
| EBITDA | -665,396 | -604,117 | -725,268 |
| Free Cash Flow | -534,078 | -494,442 | -500,696 |
| Rev Growth | -7.7% | -7.5% | +13.8% |
| Debt/Equity | 0.28 | 0.30 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |